Fibroblast growth factor23 is associated with axonal integrity and neural network architecture in the human frontal lobes.

dc.contributor.author

Marebwa, Barbara K

dc.contributor.author

Adams, Robert J

dc.contributor.author

Magwood, Gayenell S

dc.contributor.author

Kindy, Mark

dc.contributor.author

Wilmskoetter, Janina

dc.contributor.author

Wolf, Myles

dc.contributor.author

Bonilha, Leonardo

dc.date.accessioned

2019-05-01T16:40:21Z

dc.date.available

2019-05-01T16:40:21Z

dc.date.issued

2018-01

dc.date.updated

2019-05-01T16:40:19Z

dc.description.abstract

Elevated levels of FGF23 in individuals with chronic kidney disease (CKD) are associated with adverse health outcomes, such as increased mortality, large vessel disease, and reduced white matter volume, cardiovascular and cerebrovascular events. Apart from the well-known link between cardiovascular (CV) risk factors, especially diabetes and hypertension, and cerebrovascular damage, elevated FGF23 is also postulated to be associated with cerebrovascular damage independently of CKD. Elevated FGF23 predisposes to vascular calcification and is associated with vascular stiffness and endothelial dysfunction in the general population with normal renal function. These factors may lead to microangiopathic changes in the brain, cumulative ischemia, and eventually to the loss of white matter fibers. The relationship between FGF23 and brain integrity in individuals without CKD has hitherto not been investigated. In this study, we aimed to determine the association between FGF23, and white matter integrity in a cohort of 50 participants with varying degrees of CV risk burden, using high resolution structural human brain connectomes constructed from MRI diffusion images. We observed that increased FGF23 was associated with axonal loss in the frontal lobe, leading to a fragmentation of white matter network organization. This study provides the first description of the relationship between elevated levels of FGF23, white matter integrity, and brain health. We suggest a synergistic interaction of CV risk factors and FGF23 as a potentially novel determinant of brain health.

dc.identifier

PONE-D-18-01916

dc.identifier.issn

1932-6203

dc.identifier.issn

1932-6203

dc.identifier.uri

https://hdl.handle.net/10161/18490

dc.language

eng

dc.publisher

Public Library of Science (PLoS)

dc.relation.ispartof

PloS one

dc.relation.isversionof

10.1371/journal.pone.0203460

dc.subject

Endothelium, Vascular

dc.subject

Frontal Lobe

dc.subject

Axons

dc.subject

Humans

dc.subject

Cardiovascular Diseases

dc.subject

Fibroblast Growth Factors

dc.subject

Magnetic Resonance Imaging

dc.subject

Risk Factors

dc.subject

Cohort Studies

dc.subject

Neural Networks (Computer)

dc.subject

Middle Aged

dc.subject

Female

dc.subject

Male

dc.subject

Renal Insufficiency, Chronic

dc.subject

Vascular Stiffness

dc.subject

Vascular Calcification

dc.subject

White Matter

dc.title

Fibroblast growth factor23 is associated with axonal integrity and neural network architecture in the human frontal lobes.

dc.type

Journal article

pubs.begin-page

e0203460

pubs.issue

9

pubs.organisational-group

School of Medicine

pubs.organisational-group

Duke

pubs.organisational-group

Duke Clinical Research Institute

pubs.organisational-group

Institutes and Centers

pubs.organisational-group

Population Health Sciences

pubs.organisational-group

Basic Science Departments

pubs.organisational-group

Medicine, Nephrology

pubs.organisational-group

Medicine

pubs.organisational-group

Clinical Science Departments

pubs.publication-status

Published

pubs.volume

13

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Fibroblast growth factor23 is associated with axonal integrity and neural network architecture in the human frontal lobes.pdf
Size:
4.15 MB
Format:
Adobe Portable Document Format